000 | 01104 a2200301 4500 | ||
---|---|---|---|
005 | 20250514020115.0 | ||
264 | 0 | _c20011231 | |
008 | 200112s 0 0 eng d | ||
022 | _a1471-2598 | ||
024 | 7 |
_a10.1517/14712598.1.1.3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBhatia, V | |
245 | 0 | 0 |
_aNovel approaches to allogeneic stem cell therapy. _h[electronic resource] |
260 |
_bExpert opinion on biological therapy _cJan 2001 |
||
300 |
_a3-15 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aGraft vs Host Disease |
650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia _xtherapy |
650 | 0 | 4 |
_aMyeloablative Agonists _xtherapeutic use |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 |
_aTransplantation, Homologous _xmethods |
700 | 1 | _aPorter, D L | |
773 | 0 |
_tExpert opinion on biological therapy _gvol. 1 _gno. 1 _gp. 3-15 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/14712598.1.1.3 _zAvailable from publisher's website |
999 |
_c11641588 _d11641588 |